| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-09-30 FY | 2023-06-30 FY | 2023-03-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $1.30M | $1.13M | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | $1.30M | $1.07M | $1.55M | – | – | – | $1.20M | $816.36K |
| Operating Income | – | – | – | – | – | – | – | – |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | -$14.78M | $1.99M | $3.45M | $3.10M | -$947.54K | $196.15K | $11.65M | $2.16M |
| EPS (basic) | – | – | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – | – |